Skip to main content

Series A Pharmaceutical Companies

Explore 201 pharmaceutical startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
201
Total Funding
$610.1M
Avg Funding
$24.4M
Cities
23

Export 201 Series A Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States
$55.0M
raised

Tectora Therapeutics is a biotechnology company developing oral medicines for immune-mediated diseases.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Plan-les-ouates, Switzerland
$9.5M
raised

Calypso Biotech is a biotechnology company that developes therapeutics for autoimmune diseases.

Sep 2021
Series A

Founder Contacts

41,000+ verified contacts

Issaquah, United States
$22.0M
raised

CaaMTech is developing and optimizing psychedelic compounds to build a patent portfolio.

Sep 2021
Series A

Founder Contacts

41,000+ verified contacts

Sevilla, Spain
$12.8M
raised

Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Nijmegen, The Netherlands
$17.2M
raised

Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.

Sep 2022
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 201 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Burlington, United States
$32.0M
raised

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

Sep 2022
Series A

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$39.0M
raised

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Sep 2023
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Mirai Bio provides access to end-to-end development capabilities with innovation at every step.

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

Tübingen, Germany
$13.7M
raised

ViferaXS is a clinical-stage biotechnology company developing peptide-based cancer immunotherapies.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$56.3M
raised

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 201 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Raleigh, United States
$5.0M
raised

Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Tokyo, Japan
$3.1M
raised

FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$25.0M
raised

Altis is accelerating clinical trials with AI endpoints so that drug developers can get the best new treatment to patients sooner.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$50.0M
raised

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

Sep 2025
Series A

Founder Contacts

41,000+ verified contacts

Schlieren, Switzerland
$60.4M
raised

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

Sep 2021
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 201 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Pleasanton, United States
$13.3M
raised

Graph AI develops a pharmacovigilance platform that supports patient safety and regulatory operations across the pharmaceutical lifecycle.

Sep 2026
Series A

Founder Contacts

41,000+ verified contacts

Albuquerque, United States
$3.0M
raised

Nob Hill Therapeutics is established to commercialize the first dry-powder nebulizer to treat severe respiratory diseases.

Aug 2024
Series A

Founder Contacts

41,000+ verified contacts

Columbus, United States
$12.0M
raised

Blend is a modern compounding pharmacy offering technology enabled fulfillment services to clinics, telemedicine companies and providers.

Aug 2026
Series A

Founder Contacts

41,000+ verified contacts

Oakland, United States
$70.0M
raised

Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.

Aug 2021
Series A

Founder Contacts

41,000+ verified contacts

Ascot, United Kingdom
$6.0M
raised

Actimed Therapeutics is a clinical stage biopharmaceutical company.

Aug 2023
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 201 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Zug, Switzerland
$12.4M
raised

PeakData is a software platform to identify and analyze key opinion leaders in your therapeutic area.

Aug 2022
Series A

Founder Contacts

41,000+ verified contacts

Brisbane, Australia
$8.3M
raised

Midnight Health is on a mission to provide patient-led digital first healthcare.

Aug 2022
Series A

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland
$10.1M
raised

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

Aug 2024
Series A

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States
$14.0M
raised

KaliVir Immunotherapeutics develops oncolytic viral immunotherapy programs for the treatment of cancer.

Aug 2026
Series A

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$10.0M
raised

Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.

Aug 2025
Series A

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 201 companies

Ready to Connect with Series A Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 201 series a pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked